NeurologyLive Brain Games is a weekly, Sunday-morning quiz series featuring three questions authored by clinicians and ...
In honor of SMA Awareness Month, held annually throughout August, get caught up on the latest news in spinal muscular atrophy ...
The FDA has been busy this week, making multiple decisions over just a few days. The administration kicked off the week by ...
The vice president of Neuroscience and Vaccines at Takeda discusses the clinical significance of oveporexton's FDA approval ...
In recognition of SMA Awareness Month, held annually throughout August, NeurologyLive® reviews the investigational agents ...
The American Heart Association (AHA) and American Stroke Association (ASA) have published the "2026 Guideline for Adult ...
Riley Bove, MD, an associate professor of neurology at the University of California, San Francisco, discussed phase 4 findings from the MINORE and SOPRANINO studies that examined ocrelizumab exposure ...
Welcome to NeurologyLive® 's Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive 's widespread coverage in ...
Intraoperative MRI demonstrated that the AAV2-GDNF infusions covered a mean 26% [±10%] of the putamen. Investigators also observed off-target distribution of the co-infused gadoteridol contrast agent, ...
Dustin Gable, MD, PhD, a pediatric neuromuscular neurologist at Johns Hopkins Medicine, discussed why bulbar dysfunction ...
An expanded post–RGX-111 imaging protocol uncovered spinal lesions without corresponding brain MRI masses, highlighting surveillance sensitivity rather than established treatment causality. The ...
In recognition of Spinal Muscular Atrophy (SMA) Awareness Month, held annually in August, this month’s spotlight is the phase 3 program for Biogen’s salanersen, formally known as BIIB115, which is an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results